Americans pay far higher prices for prescription drugs than do people in other wealthy countries. The reason that other countries spend so much less on drugs is that their governments negotiate prices with the pharmaceutical industry. The United States government could adopt the same approach with the Medicare drug program and use its market leverage to negotiate the same, or even lower, prices as are paid by other wealthy nations.
According to a new issue brief from Center for Economic Policy and Research, such a system would save Washington state between $500 million and $1.2 billion over 10 years. The potential savings to all states would be enormous, cumulatively between $31 billion and $73 billion over 10 years.
Every state individually could expect significant savings. California leads the way, with potential savings between $3.3 and $7.8 billion. The next six top-saving states are Florida, New York, Texas, Pennsylvania, Ohio and Illinois, all with projected savings of at least $1 billion per year. Even those states with the least potential savings, such as Wyoming, North Dakota and Vermont, would still save tens of millions of dollars over a decade.
More To Read
May 2, 2024
Baby Bonds: A Step Toward Racial and Economic Equity
The Washington Future Fund would bring this innovative, anti-racist policy to the Evergreen State
May 1, 2024
Laws Targeting LGBTQ Youth Aren’t Just Bad for Kids – They’re Bad For The Economy
The harm done by anti-LGBTQ laws expands so much further than queer children and teens
April 26, 2024
What is WA Cares and Why Does It Matter for Washingtonians?
We need to defend this important policy from billionaires looking to save a buck